Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
250.08
+15.67 (6.68%)
At close: May 13, 2025, 4:00 PM
250.08
0.00 (0.00%)
After-hours: May 13, 2025, 7:00 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| Life Science | 1.02B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Science Growth | -7.43% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Diagnostics | 1.53B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Diagnostics Growth | 1.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segments | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segments Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2011 - 2019 |
| Life Science Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Science Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Diagnostics Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Diagnostics Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segments Operating Profit |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segments Operating Profit Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Gross Income by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| Life Science Segment Profit | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Science Segment Profit Growth | -2.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Diagnostics Segment Profit | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Diagnostics Segment Profit Growth | -8.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segments Segment Profit | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segments Segment Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| United States | 1.03B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | -4.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA | 833.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA Growth | 2.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APAC | 508.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| APAC Growth | -6.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Regional | 168.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Regional Growth | 0.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|